Page not found

×

Warning message

Your search used too many AND/OR expressions. Only the first 7 terms were included in this search.

Search results

  1. Tech Connect, Vol. 6, Issue 13: Tennessee Stem Innovations Summit calls for proposals

    ... Weekly interactions: CTTC staff members work diligently to manage all disclosures and requests in a ... around small molecule therapeutics for coronary heart disease developed by Heidi Hamm and colleagues from the  Department of ...

    steelmk - 11/15/2016 - 2:57pm

  2. Enzyme protects against obesity-related heart disease

    ... Saturated fats found in high-fat diets increase the risk of heart failure. Now Manisha Gupte, PhD,  Hind Lal , PhD, and colleagues show that the presence of an enzyme called GSK-3beta in the heart is crucial to protect against obesity-related cardiac dysfunction. To ...

    sommers - 06/18/2018 - 9:44am

  3. Tech Connect, Vol. 6, Issue 19: Vanderbilt signs license agreement with student startup Metalytics LLC

    ... parties was presented.  In addition, both the private and public sector introduced detailed information about resources, such as ... is the online licensing platform sponsored by CTTC for marketing and licensing innovative software, courseware and other ... Weekly interactions: CTTC staff members work diligently to manage all disclosures and requests in a ...

    steelmk - 11/10/2016 - 7:45am

  4. Immunotherapies linked to specific heart complications

    ... inhibitors, Vanderbilt researchers have shown that heart and vessel complications include myocarditis, pericarditis, vasculitis ... the cancer cells, in rare situations it can also attack the heart and vessels, and in some cases, this can result in fatalities,” said ...

    sommers - 02/21/2019 - 9:51am

  5. Driving Innovation Forward, Dec 2017

    ... relationships with industry partners. With the support of CTTC and other administrative units on campus, the Vanderbilt Vaccine Center ... provide support for its mission to advance therapies for public benefit. Vanderbilt recognizes the opportunities that exist for deeper ...

    mullerg - 03/16/2018 - 9:41am

  6. Potential schizophrenia treatment, discovered at Vanderbilt and being developed by Neumora Therapeutics, entering Phase 1 clinical trial

    ... the therapeutic will be made available for use by the public and be monitored for safety by the FDA for as long as it is available.  ...

    sommers - 01/17/2024 - 10:08am

  7. Cardiac Innovations

    09/29/2016 CTTC currently has three active innovations that could in the future have an impact on the detection and treatment of heart disease. We are seeking commercialization and licensing partnership for ... for Blood Clot: FXII Inhibitors to Treat Thrombosis CTTC also assisted Vanderbilt researchs in launching two startup companies ...

    steelmk - 09/29/2016 - 1:36pm

  8. Biophotonics device for parathyroid ID wins R&D 100 Award

    ... Center for Technology Transfer and Commercialization  (CTTC) leads the submission on behalf of Vanderbilt University, which has now ... them to walk, took top honors in its category in 2018.  Co-inventors Michael Goldfarb, H. Fort Flowers Professor of Mechanical ...

    sommers - 11/05/2019 - 3:37pm

  9. New Insect Repellants Disrupt Olfactory Cues: A Strategy for Pest Protection

    ... http://vanderbilt.technologypublisher.com/files/sites/ncs-insect-repellent-marketing-summary1.pdf Project ID:  ...

    cttc_admin - 05/31/2023 - 2:03pm

  10. Vanderbilt highlights smart mobility research, innovative solutions at Nashville expo

    ... on Dec. 5-6 will be hosted by TennSMART,  a consortium co-founded by Vanderbilt in 2018.  The event will highlight groundbreaking ... along with Cara Ince, director of research and innovation public partnerships, and Chris Rowe, executive director for industry ...

    sommers - 12/05/2023 - 1:07pm